You just read:

MabVax Therapeutics' HuMab-5B1 Cancer Therapeutic Featured in Presentation at AACR Special Meeting on Pancreatic Cancer

News provided by

MabVax Therapeutics Holdings, Inc.

May 16, 2016, 08:00 ET